Potassium and long QT syndrome: a new look at an old therapy.
Bisinov
Elizabeth
E
Mitchell
James H
JH
January
Craig T
CT
D002317:Cardiovascular Agents / Q000097:blood / Q000627:therapeutic use*; D027682:Cation Transport Proteins; D002986:Clinical Trials as Topic; D004268:DNA-Binding Proteins; D000072237:ERG1 Potassium Channel; D051638:Ether-A-Go-Go Potassium Channels; D006331:Heart Diseases / Q000188:drug therapy / Q000235:genetics / Q000503:physiopathology; D006801:Humans; D008133:Long QT Syndrome / Q000188:drug therapy* / Q000235:genetics / Q000503:physiopathology; D011188:Potassium / Q000097:blood / Q000627:therapeutic use*; D015221:Potassium Channels / Q000235:genetics; D024642:Potassium Channels, Voltage-Gated; D015534:Trans-Activators; D000071230:Transcriptional Regulator ERG
D002317:Cardiovascular Agents; D027682:Cation Transport Proteins; D004268:DNA-Binding Proteins; C072312:ERG protein, human; D000072237:ERG1 Potassium Channel; D051638:Ether-A-Go-Go Potassium Channels; C092509:KCNH6 protein, human; D015221:Potassium Channels; D024642:Potassium Channels, Voltage-Gated; D015534:Trans-Activators; D000071230:Transcriptional Regulator ERG; D011188:Potassium